Figure 3. Cumulative Incidence of Severe COVID-19 Breakthrough Illness by HIV Status and Primary Vaccination Series Type Among People With HIV (PWH) and People Without HIV (PWoH).

Graphs show incidence of illness by primary vaccination series type (A, log-rank test for Johnson & Johnson, P = .40; B, log-rank test for Pfizer, P = .67; C, log-rank test for Moderna, P = .15) and by primary series and additional vaccine doses (D, log-rank test, P = .02).Shaded areas denote 95% CIs.